Fig. 1: Treatment algorithms for WM.
From: Managing Waldenström’s macroglobulinemia with BTK inhibitors

Figure adapted from DGHO-onkopedia guidelines [12]. RTX rituximab.
From: Managing Waldenström’s macroglobulinemia with BTK inhibitors
Figure adapted from DGHO-onkopedia guidelines [12]. RTX rituximab.